The effect of dry-weight reduction guided by lung ultrasound on ambulatory blood pressure in hemodialysis patients: a randomized controlled trial.


Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
06 2019
Historique:
received: 20 11 2018
revised: 04 02 2019
accepted: 07 02 2019
pubmed: 28 4 2019
medline: 22 9 2020
entrez: 28 4 2019
Statut: ppublish

Résumé

Approximately 85% of hemodialysis patients are hypertensive, but less than 30% achieve adequate blood pressure (BP) control. Reduction of volume overload is fundamental for BP control, but clinical criteria to estimate dry-weight are inaccurate. In the present study we examined the effect of dry-weight reduction with a lung-ultrasound-guided strategy on ambulatory BP in 71 clinically euvolemic hemodialysis patients with hypertension. Patients were equally randomized into an active group, following a strategy for dry-weight reduction guided by pre-hemodialysis lung ultrasound, and a control group with standard-of-care treatment. All patients underwent 48-hour ambulatory BP monitoring (ABPM) at baseline and after eight weeks. Overall, more patients in the active than in the control group had dry weight reduction, 54.3% compared to 13.9%, respectively. The ultrasonographic-B line change during follow-up was significantly different (-5.3±12.5 in active versus +2.2±7.6 in control group), which corresponded to significant differences in dry weight changes between the groups. The magnitude of reductions in 48-hour systolic BP (-6.61±9.57 vs. -0.67±13.07) and diastolic BP (-3.85±6.34 vs. -0.55±8.28) was significantly greater in the active group. Similarly, intradialytic BP, 44-hour BP, and daytime or night-time systolic/diastolic BP during both days of the interdialytic interval were significantly reduced in the active group but remained unchanged in the control group. The percentage of patients experiencing one or more intradialytic hypotensive episodes was marginally lower in the active group (34.3% vs. 55.6%). Thus, a lung-ultrasound-guided strategy for dry-weight reduction can effectively and safely reduce ambulatory BP levels in hemodialysis patients. Clinical implementation of this simple technique can help increase BP control in this population.

Identifiants

pubmed: 31027889
pii: S0085-2538(19)30270-4
doi: 10.1016/j.kint.2019.02.018
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1505-1513

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Auteurs

Charalampos Loutradis (C)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece.

Pantelis A Sarafidis (PA)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece. Electronic address: psarafidis11@yahoo.gr.

Robert Ekart (R)

Department of Nephrology, University Clinical Centre Maribor, Maribor, Slovenia.

Christodoulos Papadopoulos (C)

3rd Department of Cardiology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Vasileios Sachpekidis (V)

Department of Cardiology, Papageorgiou Hospital, Thessaloniki, Greece.

Maria Eleni Alexandrou (ME)

Department of Nephrology, Papageorgiou Hospital, Thessaloniki, Greece.

Dorothea Papadopoulou (D)

Department of Nephrology, Papageorgiou Hospital, Thessaloniki, Greece.

Giorgos Efstratiadis (G)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece.

Aikaterini Papagianni (A)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece.

Gerard London (G)

Hospital and FCRIN INI-CRCTC, Manhes, France.

Carmine Zoccali (C)

CNR-IFC Clinical Epidemiology of Renal Diseases and Hypertension, Reggio Calabria, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH